Smith Chas P & Associates Pa Cpas Novo Nordisk A S Transaction History
Smith Chas P & Associates Pa Cpas
- $1.78 Billion
- Q2 2025
A detailed history of Smith Chas P & Associates Pa Cpas transactions in Novo Nordisk A S stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 197,466 shares of NVO stock, worth $11 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
197,466
Previous 81,053
143.63%
Holding current value
$11 Million
Previous $5.63 Million
142.16%
% of portfolio
0.77%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,723Shares Held
313MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.05 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$821 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$796 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$701 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$648 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $126B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...